Lung Sarcomatoid Carcinoma

Lung Sarcomatoid Carcinoma, also known as sarcomatoid carcinoma of the lung, is related to carcinosarcoma and small cell cancer of the lung. An important gene associated with Lung Sarcomatoid Carcinoma is KRAS (KRAS Proto-Oncogene, GTPase), and among its related pathways/superpathways are Signal Transduction and RAF/MAP kinase cascade. The drugs Durvalumab and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include lung and lymph node, and related phenotypes are Decreased viability and neoplasm